Business Description
Hadasit Bio-Holdings is an Israeli life sciences investment company founded in 2005 and headquartered in Jerusalem. The company backs a range of medical research projects, including new protein-based cancer treatments, cell therapies for serious immune disorders, and stem cell approaches to treating eye disease. Its portfolio also covers experimental therapies for patients with severe infections, graft-versus-host disease following bone marrow transplants, and complications arising from coronavirus.
